| HOME >> MEDICINE >> TECHNOLOGY |
1 Executive Summary 3
2 About Cancer Highlights™ 5
2.1 Cancer Focus Areas 5
2.2 Subscribe Today and Start Saving 6
2.2.1 Type of License 6
2.3 Additional Information 6
2.4 BioSeeker Group's Oncology Team 6
3 Methodology 7
3.1 Cancer Highlights Five Pillar Drug Assessment 7
4 Table of Contents 9
4.1 List of Figures 19
4.2 List of Tables 19
5 Introduction 26
5.1 The Scope of this Report 26
5.2 Definitions 29
5.3 Abbreviations 29
6 Consider the Therapeutic Target Among Lymphoma Drugs for the Highest Therapeutic Outcome and Return on Investment 30
6.1 Drug Repositioning in Oncology 30
6.2 Introduction to Targets of Lymphoma Drugs 31
6.2.1 Acid Phosphatase Activity Targets 38
6.2.2 Auxiliary Transport Protein Activity Targets 39
6.2.3 Carboxy-lyase Activity Targets 40
6.2.4 Caspase Activator Activity Targets 41
6.2.5 Catalytic Activity Targets 42
6.2.6 Cell Adhesion Molecule Activity Targets 50
6.2.7 Chaperone Activity Targets 53
6.2.8 Chemokine Activity Targets 56
6.2.9 Cysteine-type Peptidase Activity Targets 58
6.2.10 Cytokine Activity Targets 61
6.2.11 Deaminase Activity Targets 68
6.2.12 DNA Binding Targets 69
6.2.13 DNA Repair Protein Targets 71
6.2.14 DNA Topoisomerase Activity Targets 72
6.2.15 DNA-directed DNA Polymerase Activity Targets 76
6.2.16 DNA-methyltransferase Activity Targets 82
6.2.17 G-protein Coupled Receptor Activity Targets 83
6.2.18 Glutathione Transferase Activity Targ
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |